Screening

Non-invasive screening procedures quickly provide medical personnel with the desired information. This is by no means an insignificant aspect of every day medicine, where it is often necessary to hurry. For example, the non-invasive measurement of the transcutaneous bilirubin value (TcB) represents a gentle, pain-free alternative to the conventional jaundice measurement procedure, as it is not necessary to remove any blood. In addition, it also reduces the risk of hospital borne infections. This is not only an important aspect for patients, but also of considerable importance when it comes to costs. According to a US study published in 2000, hospital-acquired infections cause annual costs of 29 billion dollars in American hospitals ³. Furthermore, no consumables are used in non-invasive bilirubin measurement, which also contributes to a reduction in costs.

In the field of alcohol and drug test measurement, non-invasive procedures can also provide prompt information on whether a patient has consumed any substances before arriving in the emergency room and, if so, which substances. The prompt provision of results allows staff to implement suitable measures quickly. Non-invasive screening applications can also simultaneously contribute to cost reduction in the hospital, as expensive laboratory examinations can often be avoided. Non-invasive screening is also a more comfortable option than invasive methods, as no blood must be taken. This helps to avoid pain and stress.

Dräger is a leading provider of non-invasive medical technology and offers a comprehensive range of products in the field of non-invasive screening: